G. Lavie
Impact in
- Toxicology top 5%
- Immunology top 10%
- T-cell and B-cell Immunology
Papers in
-
- Immunotherapy and Immune Responses 2
- Co-authors
- Daniel MerueloDavid LavieDorothea Zucker‐FranklinE. C. FranklinY. MAZURBrandi LevinM. MandelGloria Gallo
- Journals
- Transfusion (2 papers)The Journal of Immunology (2 papers)Proceedings of the National Academy of Sciences (2 papers)British Journal of Cancer (1 paper)Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (1 paper)
- Partner nations
- IsraelUnited States
In The Last Decade
G. Lavie
20 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 96
- Toxicology 55
- Immunology 254
- Virology 52
- Pulmonary and Respiratory Medicine 277
- Molecular Biology 537
Countries citing papers authored by G. Lavie
This map shows the geographic impact of G. Lavie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Lavie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Lavie more than expected).
Fields of papers citing papers by G. Lavie
This network shows the impact of papers produced by G. Lavie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Lavie. The network helps show where G. Lavie may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Lavie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 14 | |
| 2 | 2004 | 36 | |
| 3 | 2001 | 40 | |
| 4 | 2001 | 18 | |
| 5 | 1999 | 79 | |
| 6 | 1995 | 88 | |
| 7 | 1995 | 1 | |
| 8 | 1989 | 175 | |
| 9 | 1988 | 359 | |
| 10 | 1987 | 2 | |
| 11 | 1987 | 1 | |
| 12 | 1986 | 56 | |
| 13 | Monoclonal anti-tuberculosis antibodies react with DNA, and monoclonal anti-DNA autoantibodies react with Mycobacterium tuberculosis. | 1986 | 91 |
| 14 | 1985 | 21 | |
| 15 | 1985 | 43 | |
| 16 | 1984 | 29 | |
| 17 | 1981 | 34 | |
| 18 | 1981 | 11 | |
| 19 | 1980 | 113 | |
| 20 | 1978 | 165 |
About G. Lavie
G. Lavie is a scholar working on Immunology, Biotechnology, Virology, Hematology and Immunology and Allergy, having authored 20 papers that have together received 1.4k indexed citations. Recurring topics across this work include Photodynamic Therapy Research Studies (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (4 papers), Cancer therapeutics and mechanisms (3 papers), Chemical Synthesis and Analysis (2 papers), Blood disorders and treatments (2 papers), Immunotherapy and Immune Responses (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Toxicology (55 citations), Immunology (254 citations), Virology (52 citations), Pulmonary and Respiratory Medicine (277 citations) and Molecular Biology (537 citations). G. Lavie has collaborated with scholars based in Israel and United States. Frequent co-authors include Daniel Meruelo, David Lavie, Dorothea Zucker‐Franklin, E. C. Franklin, Y. MAZUR, Brandi Levin, M. Mandel, Gloria Gallo, Fred Valentine and David B. Weiner. Their work appears in journals such as Transfusion, The Journal of Immunology, Proceedings of the National Academy of Sciences, British Journal of Cancer and Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.